CRYOVALVE SG- PULMONARY VALVE AND CONDUIT SGPV00

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2014-07-02 for CRYOVALVE SG- PULMONARY VALVE AND CONDUIT SGPV00 manufactured by Cryolife, Inc..

Event Text Entries

[21725981] (b)(6), cvor coordinator of (b)(6) hospital, stated that on (b)(6) 2014, they had a pulmonary valve fracture. It had to be explanted and it was kept for evaluation.
Patient Sequence No: 1, Text Type: D, B5


[22086683] This investigation is currently ongoing. Any additional information will be provided in the follow-up report.
Patient Sequence No: 1, Text Type: N, H10


[30252868] Cryolife representative stated that he received a voicemail stating that the hospital had a pulmonary valve fracture and it was kept for evaluation. The synergraft pulmonary valve and conduit was received in a cup with enough solution as to be completely submerged. The valve was transected at the bifurcation. A 0. 8cm tear was located in the muscle band, 2. 3cm from the transection at the bifurcation, and extended into the left semilunar cusp (lsc). Three cracks were observed in the internal muscle band, one of which extended from the anterior/right (ar) post to the left/right (lr) post. Another crack was observed in the conduit. It was also noted that there were no signs that the allograft had been implanted. There were no sutures, no holes left by suturing, and no remnants of patient blood. The damage observed is consistent with damage caused by mishandling the allograft while in the frozen state. It is likely that the damage occurred at the user facility; cryolife personnel are trained to properly handle cryopreserved allografts and no errors or deficiencies were found in the processing record reviews. The instructions for use states, "cryopreserved allografts are fragile and must be handled with care while in the frozen state to avoid causing damage to the allograft" and "cardiac allografts are human biological tissues and, as such present considerable anatomical variation. Specific allograft attributes (representing normal variation) and donor-specific information is described in the allograft diagram and the certificate of assurance supplied with each allograft. "
Patient Sequence No: 1, Text Type: N, H10


[30252869] (b)(6), cvor coordinator of (b)(6), stated that on (b)(6) 2014 they had a pulmonary valve fracture it was kept for evaluation.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1063481-2014-00026
MDR Report Key3910206
Report Source06
Date Received2014-07-02
Date of Report2014-06-24
Date of Event2014-06-23
Date Mfgr Received2014-06-24
Date Added to Maude2014-07-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactSANDRA O'REILLY
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal30144
Manufacturer Phone7704193355
Manufacturer G1CRYOLIFE, INC.
Manufacturer Street1655 ROBERTS BLVD., NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal Code30144
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCRYOVALVE SG- PULMONARY VALVE AND CONDUIT
Generic NameHEART VALVE ALLOGRAFT
Product CodeOHA
Date Received2014-07-02
Returned To Mfg2014-07-01
Model NumberSGPV00
Lot Number10372214
ID NumberDONOR NUMBER: 128086
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCRYOLIFE, INC.
Manufacturer Address1655 ROBERTS BLVD., NW KENNESAW GA 30144 US 30144


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2014-07-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.